Showing results (51-60 of 66) with videos related to
Sort By:
Pageof 7
Angewandte Chemie (International Ed. in English)|January 19, 2021
Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine*Sonia Jangra, Jana De Vrieze, Angela Choi, et al.Ebiomedicine|April 2, 2022
Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individualsNicolás A Muena, Tamara García-Salum, Catalina Pardo-Roa, et al.Cell|June 30, 2021
SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2Fatima Amanat, Mahima Thapa, Tinting Lei, et al.Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies and targets both the NTD and the RBDFatima Amanat, Mahima Thapa, Tinting Lei, et al.Nature Immunology|October 15, 2025
Influenza vaccine based on AS03-adjuvanted chimeric HA induces long-lived stalk-specific plasma cells in bone marrow and lymph nodes of nonhuman primatesAkil Akhtar, Tiffany M Styles, Chunyang Gu, et al.Journal of Virology|February 8, 2019
Broad Hemagglutinin-Specific Memory B Cell Expansion by Seasonal Influenza Virus Infection Reflects Early-Life Imprinting and Adaptation to the Infecting VirusBrenda L Tesini, Preshetha Kanagaiah, Jiong Wang, et al.Nature Microbiology|August 14, 2019
The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strainHongquan Wan, Jin Gao, Hua Yang, et al.Nature|September 1, 2020
Human germinal centres engage memory and naive B cells after influenza vaccinationJackson S Turner, Julian Q Zhou, Julianna Han, et al.Immunity|July 28, 2023
Human anti-N1 monoclonal antibodies elicited by pandemic H1N1 virus infection broadly inhibit HxN1 viruses in vitro and in vivoLena Hansen, Meagan McMahon, Hannah L Turner, et al.Vaccines|November 13, 2020
Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive AntibodiesJuan Manuel Carreño, Jacqueline U McDonald, Tara Hurst, et al.Pageof 7